CENT vs SPB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CENT and SPB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CENT and SPB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Central Garden & Pet sells the physical goods that keep a lawn alive and a pet fed. Two segments carry the whole company: Garden, which covers grass seed, wild bird feed, fertiliser, controls and pottery under names such as Pennington, Amdro and Sevin, and Pet, which spans aquatics, small animal and reptile supplies, dog and cat treats, flea and tick products and equine care under Kaytee, Aqueon, Farnam and Comfort Zone. Distribution runs mostly through big box retail, pet specialty chains, grocery and e-commerce, which is why the business is more sensitive to retailer inventory decisions and to a wet or dry spring than a typical packaged goods name. Fiscal 2025 net sales landed at ~$3.13B, and trailing twelve month sales sit at ~$3.08B after management deliberately exited a low margin pet distribution business.

Full CENT guide

Spectrum Brands Holdings owns and operates consumer brands across three reporting segments. Global Pet Care is the largest and includes Tetra and Marineland in aquatics plus FURminator, Nature's Miracle, DreamBone and 8-in-1 in companion animal. Home & Garden sells household pest and lawn control under Spectracide, Cutter, Hot Shot and Black Flag, a business that swings with spring weather and retailer order timing. Home & Personal Care covers small kitchen and grooming appliances under Remington, George Foreman and Russell Hobbs. The company does not own premium category leaders in most of these aisles. It owns the value and mid-tier positions, sold largely through Walmart, Amazon, Home Depot, Lowe's and other big-box retail, which makes shelf space and retailer inventory decisions a bigger swing factor than brand pricing power.

Full SPB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CENT drivers: The share class spread is the first variable, not a footnote; Central issues Class A, which quietly dilutes CENT's share of the equity.
• SPB drivers: Pet care as the growth and margin anchor; Home & Garden operating leverage when the weather cooperates.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Governance is the structural risk specific to this ticker: a CENT holder owns one vote per share in a company where unlisted Class B holders may cast up to 49% of total votes, so minority influence over board composition or a change of control is limited by design. For SPB, spectrum's brands sit largely in value and mid-tier price points sold through a handful of very large retailers, so a shelf-reset decision at Walmart or a retailer inventory correction can move a quarter more than consumer demand does.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CENT if you believe its drivers more; SPB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CENT and SPB guides.

CENT. One set of earnings supports two different multiples here, because CENT at ~$43.82 and CENTA at ~$38.20 divide the same ~$2.67 of trailing EPS. Screeners commonly quote a ~$2.7B market cap for Central by applying CENT's price to all ~62.6 million shares across every class, whereas valuing each class at its own quoted price puts the figure nearer ~$2.5B, a gap worth knowing before comparing Central's enterprise value of ~$3.15B or its ~9.5x EV/EBITDA against single class peers. Beta of ~0.54 and a ~5.4% net margin describe a low volatility, thin margin consumer goods business rather than a growth story.

SPB. The multiple looks ordinary for a consumer staples name until you notice the share count. About 23 million shares outstanding against roughly $2.8 billion of revenue means the enterprise trades at a fraction of one times sales, while the earnings multiple sits in the high teens because margins are thin at the consolidated level. Guidance for fiscal 2026 calls for net sales flat to up low single digits, adjusted EBITDA up low to mid single digits, and roughly 50% conversion of adjusted EBITDA into adjusted free cash flow. The stock has run from a 52-week low near $50 to about $88, close to its $92 high, so the discount that attracted value buyers a year ago is materially narrower.

Headline figures (approximate, August 2026): CENT shows revenue (ttm) ~$3.08B, net income (ttm) ~$166M, diluted eps (ttm) ~$2.67, p/e on cent vs centa ~16.4x vs ~14.3x; SPB shows revenue (ttm) ~$2.82 billion, down ~3.8% year over year, fiscal q2 2026 net sales ~$709 million, up ~4.9% reported and ~1.5% organic, fiscal q2 2026 adjusted ebitda ~$84 million, up ~$12.7 million year over year, net income / eps (ttm) ~$126 million and ~$5.24 per share.

CENT and SPB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CENT and SPB exposure against your real portfolio. It is not an investment adviser.